Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

 

Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019
Avatar

Managing M0CRPC with Androgen Receptor Antagonists: Analysis of Top New Trials - PROSPER (Enzalutamide), SPARTAN (Apalutamide), and ARAMIS (Darolutamide)

By Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019 FEATURING Alicia Morgans
By Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019 FEATURING Alicia Morgans
718 views
June 11, 2019
0 Comments
Login to view comments. Click here to Login
Topics in Cancer
22:16
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Metastatic Pancreatic Cancer Therapy, What's New on the Horizon…

Feat. D. Sigal
09:21
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Background of the Biochemically Recurrent Prostate Cancer: How to Se…

Feat. A. Morgans
09:51
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Biochemically Recurrent Prostate Cancer: Optimal Timing and Medical …

Feat. A. Morgans
16:45
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Managing M0CRPC with Androgen Receptor Antagonists: Analysis of Top …

Feat. A. Morgans
19:54
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

PD-L1 Expression Based Treatment of Advanced NSCLC: IO as a Systemic…

Feat. M. Johnson
15:37
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

TMB as a Biomarker of Efficacy in PD-1/CTLA-4-Based Treatment of Adv…

Feat. M. Johnson
11:09
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Historical Insight in Pancreatic Cancer: Anatomy, Challenges and Pat…

Feat. D. Sigal
09:47
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Sequencing Chemotherapy as a First and Second-Line Treatment of Meta…

Feat. D. Sigal
13:57
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Chemotherapy for Metastatic Colorectal Cancer - 5FUL, Irinotecan, Ox…

Feat. J. Hecht
18:07
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Biological (Angiogenesis Inhibitors and EGFR) and Targeted Therapies…

Feat. J. Hecht
15:46
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Basal Cell Carcinoma: Disease Overview, Approved Therapies and Futur…

Feat. K. Bollin
14:01
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Merkel Cell Carcinoma: Disease Overview, Approved Therapies and Futu…

Feat. K. Bollin
10:28
Scripps Cancer Center's 39th Annual Conference: Clinical Hematology & Oncology 2019

Cutaneous Squamous Cell Carcinoma: Disease Overview, Approved Therap…

Feat. K. Bollin